BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2258095)

  • 1. [Bedtime administration of metformin may reduce insulin requirements].
    Ravina A; Minuchin O
    Harefuah; 1990 Oct; 119(7-8):200-3. PubMed ID: 2258095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin therapy in the type 2 obese diabetic patient. Supplementing the deficit].
    Matthaei S; Häring HU
    MMW Fortschr Med; 2001 May; 143(21):35-7. PubMed ID: 11420829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS; Melander A
    Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of obese diabetic patients using glucophage retard].
    Munk W
    Z Allgemeinmed; 1975 May; 51(14):681-3. PubMed ID: 1108460
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of personalized diabetes treatment plans using a two-delay model.
    Kissler SM; Cichowitz C; Sankaranarayanan S; Bortz DM
    J Theor Biol; 2014 Oct; 359():101-11. PubMed ID: 24931673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results in the treatment of diabetes with glucophage retard].
    Beyer G
    Ther Ggw; 1975 Sep; 114(9):1426-37. PubMed ID: 1103353
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas.
    Gin H; Slama G; Weissbrodt P; Poynard T; Vexiau P; Klein JC; Tchobroutsky G
    Diabetologia; 1982 Jul; 23(1):34-6. PubMed ID: 6749582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in treatment with insulin. III. Intensive conventional insulin therapy--practical examples of application].
    Skalski M; Szurkowska M; Sieradzki J
    Przegl Lek; 1992; 49(7):239-41. PubMed ID: 1297156
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of early morning hyperglycemia: is it due to Somogyi effect or dawn phenomenon?
    DeLawter DE
    Md Med J; 1991 May; 40(5):391. PubMed ID: 2041464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of glucophage on insulin secretion and insulin activity].
    Lavieuville M
    Journ Annu Diabetol Hotel Dieu; 1969; 10():407-10. PubMed ID: 5376998
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new salt of metformin proposed in the oral treatment of diabetes: embonate (or pamoate) of metformin].
    Journ Annu Diabetol Hotel Dieu; 1977; ():382-5. PubMed ID: 894877
    [No Abstract]   [Full Text] [Related]  

  • 18. [ATTEMPTED THERAPY OF SEVERE FORMS OF DIABETES MELLITUS WITH A BIGUANIDE PREPARATION "GLUCOPHAGE" (LA 6023)].
    MICULINIC R; JAKSIC Z; SKRABALO Z
    Lijec Vjesn; 1963 Nov; 85():1279-86. PubMed ID: 14097629
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of diabetes mellitus with mixtures of insulin retard and seminal insulin].
    POULSEN JE
    Ugeskr Laeger; 1949 Sep; 111(37):1029-31. PubMed ID: 15404861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucophage Symposium--NIDD today. Helsingôr, Denmark, September 7-8, 1990. Proceedings].
    Internist (Berl); 1990 Nov; 31(11 Suppl [GLUCOPHA]):1-12. PubMed ID: 1980122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.